Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust

3 Respiratory system

MHRA:Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects


The following acronyms may be mentioned in this section in reference to inhalers

  • MDI- Metered dose inhaler
  • DPI- Dry powder inhaler
  • BAA- Breath actuated aerosol
  • ICS- Inhaled corticosteroid
  • SABA- Short-acting bronchodilator
  • LABA- Long-acting bronchodilator
  • SAMA- Short-acting muscarinic
  • LAMA - Long-acting muscarinic

Local guidance


IESCCG Asthma Action Plan

NEECCG Asthma plan (Asthma UK)

Joint Asthma quick reference guide - adults

Asthma quick reference guide – children (5yrs-12yrs)

Asthma quick reference guide – children (over 12yrs)

Asthma quick reference guide – children (under 5yrs)

Asthma step down guidance - adults


Joint COPD Quick Reference Guide

IESCCG COPD action plan

NEECCG COPD patient passport

Other documents

Inhaler switching

03-04-02 Omalizumab

Benralizumab Fasenra

A humanised monoclonal antibody that interferes with interleukin-5 receptor binding, thereby reducing the survival of eosinophils and basophils.

For severe oesinophilic asthma (specilaist use only).

Initiated  from a specialist centre eg Addenbrrokes

Link  NICE TA 565 Benralizumab for treating severe eosinophilic asthma

Red Hospital View adult BNF  View SPC online  View childrens BNF  HCD
Omalizumab Xolair®
Link  NICE TA278: Omalizumab for treating allergic asthma
Link  NICE TA339: Omalizumab for previously treated chronic spontaneous urticaria

Red Hospital View adult BNF  View SPC online  View childrens BNF  HCD